Heart Disease Clinical Trials in Cleveland

Showing 81-100 of 505 trials

Vascular Lab Resource (VLR) Biorepository

NCT05628948

This is a study of biomarkers obtained from prospectively collected subject samples and their correlation with cardiovascular and metabolic diseases. The purpose of this initiative is to develop an enduring tool to allow for collaborative research between clinicians at Cleveland Clinic Main Campus and basic scientists at the Lerner Research Institute. This collaboration will allow resources to be available to clinical and basic researchers alike. This tool will enable research of vascular disease in the Vascular Lab and will leverage this valuable asset to the fullest extent to allow for interdepartmental collaboration.

Cardiovascular DiseasesMetabolic DiseasePeripheral Artery Disease+13 more

The Cleveland Clinic500 participantsStarted Nov 2019

Cleveland, Ohio, United States

Active Not RecruitingNA< 1 mile

SyncAV Post-Market Trial

NCT04100148

The SyncAV Post-Market Trial is a prospective, randomized, multi-center trial performed to determine if cardiac resynchronization therapy (CRT) devices programmed with SyncAV ON improve long-term CRT response compared to devices programmed with conventional CRT through evaluation of changes in left ventricular (LV) reverse remodeling.

Congestive Heart Failure

Abbott Medical Devices1,686 participantsStarted Oct 2019

Huntsville, Alabama, United States • Phoenix, Arizona, United States • Scottsdale, Arizona, United States +101 more locations

Vascular Lab Resource (VLR) Biorepository

SyncAV Post-Market Trial

Heart Disease Trials in Other Cities

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

Sequential Cystatin C Levels and Renal Impairment in Acute Heart Failure

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)

A SkeleTal Muscle Recovery Intervention With Dietary Protein in Heart Failure

Post Approval Study (PAS) of the OPTIMIZER Smart and CCM Therapy

A Study to Assess Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Reduced Ejection Fraction (Cycle-1-REF)

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR

Prevention of Serious Adverse Events Following Angiography

Acupuncture on Cardiac and Autonomic Function in Human Heart Failure

Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)

A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-035)

A Extension Study of Udenafil in Adolescents

Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 Diabetes

Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension Group 2 (PreVail-PH2 Study)

Innovative Support for Patients With SARS-COV2 Infections (COVID-19) Registry (INSPIRE)

A Feasibility Study of the Millipede Transcatheter Annuloplasty Ring System in Patients With Functional Mitral Regurgitation

Accuracy of a Cuffless Photoplethysmography (PPG) Chest-Patch Monitor for 24-hour Ambulatory Blood Pressure Monitoring (ABPM)

Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)

Other Conditions in Cleveland